Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „exposure“
Suchtreffer
Begriffe & Kennungen
Abiraterone Mylan · 4.5 · Potential to affect exposures to other medicinal products Abiraterone is an inhibitor of the hepatic drug-meta
Eintrag öffnenAblymico · 4.5 · Liraglutide did not change the overall exposure of atorvastatin following single dose administration of atorva
Eintrag öffnenAblymico · 4.5 · Liraglutide did not change the overall exposure of griseofulvin following administration of a single dose of g
Eintrag öffnenAblymico · 4.5 · Liraglutide did not change the overall exposure of paracetamol following a single dose of 1 000 mg. Paracetamo
Eintrag öffnenAbseamed · 4.8 · Paediatric population with chronic renal failure on haemodialysis The exposure of paediatric patients with chr
Eintrag öffnenAclasta · 4.5 · In patients with renal impairment, the systemic exposure to concomitant medicinal products that are primarily
Eintrag öffnenAdcetris · 4.5 · Co-administration of brentuximab vedotin did not affect the plasma exposure of AVD.
Eintrag öffnenAdcetris · 4.5 · Co-administration of brentuximab vedotin is not expected to affect the exposure of CHP.
Eintrag öffnenAdcetris · 4.5 · The pharmacokinetics of ADC and MMAE have not been characterized in the setting of BrECADD. Exposures of brent
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Oral contraceptive At steady-state, tadalafil (40 mg once per day) increased ethinylestradiol exposure (AUC) b
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Oral contraceptive At steady-state, tadalafil (40 mg once per day) increased ethinylestradiol exposure (AUC) b
Eintrag öffnenAdempas · 4.5 · 9 Smoking In cigarette smokers riociguat exposure is reduced by 50-60% (see section 5.2). Therefore, patients
Eintrag öffnenAdempas · 4.5 · Smoking In cigarette smokers riociguat exposure is reduced by 50-60% (see section 5.2). Therefore, patients ar
Eintrag öffnenAdtralza · 4.8 · Anti-drug-antibody (ADA) responses were not associated with any impact on tralokinumab exposure, safety, or ef
Eintrag öffnenAdvate · 4.8 · Clinical studies with ADVATE included 418 subjects with at least one exposure to ADVATE reporting in total 93
Eintrag öffnenAdvate · 4.8 · Clinical studies with ADVATE included 418 subjects with at least one exposure to ADVATE reporting in total 93
Eintrag öffnenAimovig · 4.5 · No effect on exposure of co-administered medicinal products is expected based on the metabolic pathways of mon
Eintrag öffnenAkynzeo · 4.5 · Chemotherapeutic medicinal products (docetaxel, etoposide, cyclophosphamide) Exposure to docetaxel and etoposi
Eintrag öffnenAkynzeo · 4.5 · Chemotherapeutic medicinal products (docetaxel, etoposide, cyclophosphamide) Exposure to docetaxel and etoposi
Eintrag öffnenAkynzeo · 4.5 · Chemotherapeutic medicinal products (docetaxel, etoposide, cyclophosphamide) Exposure to docetaxel and etoposi
Eintrag öffnen